Clinical Trials Browser

OTHER × Castration-resistant Prostate Cancer × Crizotinib × Clear all

NCT02207504 2022-01-06

Crizotinib in Combination With Enzalutamide in Metastatic Castration-resistant Prostate Cancer

Phase 1 Completed

Castration-resistant Prostate Cancer